Searchable abstracts of presentations at key conferences in endocrinology

ea0014oc2.2 | Bone & calcium metabolism | ECE2007

Role of IGF system on the regulation of osteoblast aromatase activity in vitro

Palermo Claudia , Arvigo Marica , Minuto Francesco

Several studies demonstrated that IGFs stimulate aromatase activity in ovary but no data on bone are available. In the present study the role of IGF system components on aromatase action has been characterized during osteogenic differentiation in a model of rat tibial osteoblasts. At confluence (day 0) cells have been transferred to differentiating medium supplemented with 1% FCS and delta4androstenedion with or without IGF-II 3 nM, IGFBP-2 1 nM and IGFBP-3 1 nM. Cells have be...

ea0020p540 | Growth Factors | ECE2009

IGFBP3 and IGFBP2 negatively and positively modulate IGFs autocrine effect in lung cancer cell lines

Arvigo Marica , Gatto Federico , Ameri Pietro , Ferone Diego , Minuto Francesco

Insulin-like growth factors (IGFs) play an important role in the pathogenesis of several neoplasias and the IGF-binding proteins (IGFBPs) may have a role as autocrine/paracrine factors in regulating the local actions of the IGFs. In the present study we investigated IGF-I, IGF-II, IGFBP-1, IGFBP-2, and IGFBP-3 production in cultured media from three human lung cancer cell lines (Calu-3, Calu-6, A549) and in human neoplastic and normal lung tissue samples obtained at surgery fr...

ea0014p114 | (1) | ECE2007

Somatostatin and dopamine receptor regulation and effects of a new somatostatin/dopamine chimeric compound on cell proliferation of the human androgen-dependent prostate cancer cell line LNCaP

Arvigo Marica , Ruscica Massimiliano , Dozio Elena , Culler Michael D , Minuto Francesco , Motta Marcella , Magni Paolo , Ferone Diego

The increasing use of somatostatin (SRIF) analogues prompted extensive investigations on SRIF receptor (SSR) in human tumours. Human prostate cancer (PCa) may differentially express SSRs from the normal tissue. Moreover, SSR and dopamine (D) receptors (DR) may interact to form homo- and heterodimers with enhanced functional activity. In the present study, using the human androgen-dependent PCa cell line LNCaP, we investigated: 1) SSR and DR subtype expression in different cult...

ea0014p115 | (1) | ECE2007

Somatostatin receptor regulation and effects of somatostatin and somatostatin analogues on cell proliferation of the human androgen-dependent prostate cancer cell line LNCaP

Ruscica Massimiliano , Arvigo Marica , Dozio Elena , Culler Michael D , Minuto Francesco , Motta Marcella , Ferone Diego , Magni Paolo

Somatostatin (SRIF) has been demonstrated to inhibit in vitro proliferation of normal and transformed cells via SRIF receptors (SSRs). Moreover, like other neuroendocrine molecules, SRIF and SSRs may play a significant role in the progression and neuroendocrine differentiation of human prostate cancer (PCa). However, conflicting results have been reported in the literature on SSR heterogeneity and specific cell localization in PCa. In the present study, using the human ...

ea0032p514 | Endocrine tumours and neoplasia | ECE2013

Characterization and sub-cellular localization of somatostatin receptors in DU-145 and PC-3 human androgen-independent prostate cancer cells: effect of mono- and bi-specific somatostatin analogs on cell growth

Ruscica Massimiliano , Arvigo Marica , Steffani Liliana , Gatto Federico , Albertelli Manuela , Culler Michael D. , Valenti Luca , Minuto Francesco , Macchi Chiara , Ferone Diego , Magni Paolo

Somatostatin (SRIF) is an inhibitory hormone that plays a regulatory role in several cell functions including cell proliferation. SRIF acts through five specific membrane receptors (sst1-5), expressed on SRIF-target cells. SRIF and ssts may play a significant role in the progression and neuroendocrine differentiation of human prostate cancer (PCa). However, conflicting results have been reported in the literature on ssts heterogeneity and specific cell localization in PCa. Aim...

ea0026p132 | Growth factors | ECE2011

Bone turnover and mineral density in thalassemia: relationships with gh secretory status and circulating somatomedins

Danesi Leila , Cattaneo Agnese , Scacchi Massimo , Sciortino Giovanna , Vitale Giovanni , Domenica Cappellini Maria , Arvigo Marica , Ferone Diego , Minuto Francesco , Cavagnini Francesco

Introduction: Previous data from our group suggested a role for the GH/IGF1 axis in the pathophysiology of osteoporosis in thalassemia (Clin Endocrinol 69:202, 2008). The present study was aimed at evaluating the relationships between circulating IGFs and bone metabolism and density in a very large series of adult thalassemic patients.Study design: One hundred and thirty-nine patients affected by thalassemia major (mean age 32.3±7.87 years) underwen...